Information  X 
Enter a valid email address

MavIncGroVCT4 (MAV4)

  Print      Mail a friend

Tuesday 27 August, 2019

MavIncGroVCT4

Statement re NAV and Interim Dividend

RNS Number : 3152K
Maven Income & Growth VCT 4 PLC
27 August 2019
 

Maven Income and Growth VCT 4 PLC

 

Net Asset Value and Interim Dividend

 

The Directors of Maven Income and Growth VCT 4 PLC (the Company) confirm that the unaudited net asset value of the Company as at 30 June 2019 was 72.73p per Ordinary Share.

 

The Board is pleased to declare that an interim dividend in respect of the year ending 31 December 2019, of 2.00p per Ordinary Share, will be paid on 4 October 2019 to Shareholders on the register at close of business on 6 September 2019.  It should be noted that the effect of paying dividends is to reduce the NAV of the Company by the total cost of the distribution.

 

Shareholders who have not previously applied to participate in the Dividend Investment Scheme but who wish to do so in respect of the dividend payable on 4 October 2019, should ensure that a mandate form, or CREST instruction if appropriate, is received by the Registrar, Link Market Services, in advance of the dividend election date of 20 September 2019.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its interim results for the six months ended 30 June 2019 has been or will be notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

27 August 2019


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
STRPRMATMBJTBIL

a d v e r t i s e m e n t